Quaternary ammonium 3-(aminoethoxy)pyridines as antinociceptive agents

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 17, 2003, Pages 2917-2920

  Simsek, Rahime ^a   Chang Fong, Jean ^a   Lee, Mase ^a   Dukat, Malgorzata ^a   Damaj, M Imad ^a   Martin, Billy R ^a   Glennon, Richard A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINOCICEPTIVE AGENT; NICOTINIC RECEPTOR; PYRIDINE DERIVATIVE; QUATERNARY AMMONIUM DERIVATIVE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; DOSE RESPONSE; DRUG BINDING; DRUG POTENCY; METHYLATION; MOUSE; NONHUMAN; RECEPTOR AFFINITY; TAIL FLICK TEST;

EID: 0242578216     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00585-7     Document Type: Article

References (22)

1. Kowaluk E.A., Lynch K.J., Jarvis M.F. Annu. Rep. Med. Chem. 35:2000;21.
2. Decker M.W., Meyer M.D. Biochem. Pharmacol. 58:1999;917.
3. Decker M.W., Brioni J.D., Bannon A.W., Arneric S.P. Life Sci. 56:1995;545.
4. Flores C.M., Hargreaves K.M. Arneric S.P., Brioni J.D. Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities. 1999;Wiley-Liss, New York. p 359.
5. Cordero-Erausquin M., Marubio L.M., Klink R., Changeux J.-P. Trends Pharmacol. Sci. 21:2000;211.
6. Decker M.W., Meyer M.D., Sullivan J.P. Expert Opin. Investig. Drugs. 10:2001;1819.
7. Spande T.F., Garraffo H.M., Edwards M.W., Yeh H.J.C., Pannell L., Daly J.W. J. Am. Chem. Soc. 114:1992;3475.
8. Decker M.W., Arneric S.P. Arneric S.P., Brioni J.D. Neuronal Nicotinic Receptors: Pharmacology and Therapeutic Opportunities. 1999;395 Wiley-Liss, New York.
9. Glennon R.A., Maarouf R., Fahmy S., Martin B., Fan F., Yousif M., Shafik R., Dukat M. Med. Chem. Res. 2:1993;546.
10. Wilkins L.H., Grinevich V.P., Ayers J.T., Crooks P.A., Dwoskin L.P. J. Pharmacol. Exp. Ther. 305:2003;400. and references therein.
11. Cheng Y.-X., Dukat M., Dowd M., Fiedler W., Martin B., Damaj M.I., Glennon R.A. Eur. J. Med. Chem. 34:1999;177.
12. Glennon R.A., Fiedler W., Dukat M., Damaj I., Martin B. Eur. J. Med. Chem. 31:1996;875.
13. Glennon R.A., Dukat M. Pharm. Helv. Acta. 74:2000;103.
14. Lee M., Dukat M., Liao L., Damaj M.I., Martin B.R., Glennon R.A. Bioorg. Med. Chem. Lett. 12:2002;1989.
15. 3CN, followed by N-methylation and purification by column chromatography.
16. i values (at least in triplicate).
17. 22 using a 30-gauge needle attached to a glass microsyringe. The injection volume in all cases was 5 μL.
18. Dukat M., Damaj I.M., Young R., Vann R., Collins A.C., Marks M.J., Martin B.R., Glennon R.A. Eur. J. Pharmacol. 435:2002;171.
19. Grutter T., Changeux J.-P. Trends Biochem. Sci. 26:2001;459.
20. Beene D.L., Brandt G.S., Zhong W., Zacharias N.M., Lester H.A., Dougherty D.A. Biochemistry. 41:2002;10262.
21. Le Novere N., Grutter T., Changeux J.-P. Proc. Nat. Acad. Sci. U.S.A. 99:2002;3210.
22. Hyldon J.L., Wilcox G.L. Eur. J. Pharmacol. 67:1980;313.